Elekta also will hold a European Users' meeting September 7 at the Hotel Rey Juan Carlos I in Barcelona. Elekta Users will attend presentations on Elekta Treatment Solutions for management information systems, IGRT and VMAT.
*VMAT is a work in progress and currently not available for distribution.
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include, among others, Leksell Gamma Knife(R) product line for non-invasive treatment of brain disorders, Elekta Axesse(TM) for Image guided Stereotactic treatments, and Elekta Synergy(R) for intensity modulated radiation therapy (IMRT) and image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group became the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approximately 2,000 employees, Elekta's corporate headquarters is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit http://www.elekta.com.
|SOURCE Elekta, Inc.|
Copyright©2007 PR Newswire.
All rights reserved